Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03136653
What this trial is testing

Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Molecular Partners AG 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05581875
What this trial is testing

Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseNeoplasms+6 more
Hellenic Society of Hematology 48
Testing effectiveness (Phase 2)Looking for participantsNCT07284758
What this trial is testing

Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapsed/Refractory Multiple Myeloma
C4 Therapeutics, Inc. 100
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT02726581
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 170
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableNo Longer AvailableNCT02666209
What this trial is testing

Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT01297764
What this trial is testing

Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 17
Testing effectiveness (Phase 2)Study completedNCT00109993
What this trial is testing

Campath-1H + FK506 and Methylprednisolone for GVHD

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Case Comprehensive Cancer Center 34
Early research (Phase 1)Looking for participantsNCT05219721
What this trial is testing

CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Relapsed/Refractory Multiple MyelomaPlasma Cell Leukemia
Chunrui Li 18
Testing effectiveness (Phase 2)UnknownNCT03143036
What this trial is testing

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Who this might be right for
Relapse and / or Refractory Myeloma
National University Hospital, Singapore 100
Testing effectiveness (Phase 2)Ended earlyNCT00827099
What this trial is testing

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+2 more
Northside Hospital, Inc. 5
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Early research (Phase 1)Study completedNCT00858234
What this trial is testing

Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098)

Who this might be right for
Multiple Myeloma
Merck Sharp & Dohme LLC 9
Testing effectiveness (Phase 2)Looking for participantsNCT07463807
What this trial is testing

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
National Cancer Institute (NCI) 162
Large-scale testing (Phase 3)Looking for participantsNCT05730036
What this trial is testing

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 410
Testing effectiveness (Phase 2)Looking for participantsNCT07637578
What this trial is testing

Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Multiple Myeloma RefractoryMultiple Myeloma in Relapse+1 more
SCRI Development Innovations, LLC 46
Early research (Phase 1)Study completedNCT02103335
What this trial is testing

Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseRefractory Multiple MyelomaMultiple Myeloma
Celgene 38
Testing effectiveness (Phase 2)WithdrawnNCT02389543
What this trial is testing

Study of Selinexor (KPT- 330), Lenalidomide, & Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc
Very early researchTemporarily pausedNCT06691685
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.

Who this might be right for
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Next Page